Medication for Opioid Use Disorder in Federally Qualified Health Centers.
作者信息
Lindenfeld Zoe, Mauri Amanda I
机构信息
Edward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, New Jersey.
Department of Public Health Policy and Management, School of Global Public Health, New York University, New York, New York.
出版信息
JAMA Netw Open. 2025 Jan 2;8(1):e2454772. doi: 10.1001/jamanetworkopen.2024.54772.
Abstract
摘要
相似文献
1
Medication for Opioid Use Disorder in Federally Qualified Health Centers.联邦合格健康中心的阿片类药物使用障碍治疗药物
JAMA Netw Open. 2025 Jan 2;8(1):e2454772. doi: 10.1001/jamanetworkopen.2024.54772.
2
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.接受联邦合格健康中心和其他初级保健机构初级保健的被诊断患有阿片类药物使用障碍的医疗补助患者的医疗保健使用和支出。
PLoS One. 2022 Oct 18;17(10):e0276066. doi: 10.1371/journal.pone.0276066. eCollection 2022.
3
Medication-Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas.在联邦合格健康中心中，接受药物辅助阿片类药物治疗的医生：农村地区的能力滞后。
J Rural Health. 2018 Dec;34(1):14-22. doi: 10.1111/jrh.12260. Epub 2017 Aug 26.
4
Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center.在一家联邦合格健康中心，使用丁丙诺啡治疗阿片类药物使用障碍的 9 年物质使用治疗结果。
Drug Alcohol Depend. 2024 Apr 1;257:111252. doi: 10.1016/j.drugalcdep.2024.111252. Epub 2024 Mar 2.
5
Screening for Social Risk at Federally Qualified Health Centers: A National Study.在联邦合格健康中心进行社会风险筛查：一项全国性研究。
Am J Prev Med. 2022 May;62(5):670-678. doi: 10.1016/j.amepre.2021.11.008. Epub 2022 Feb 8.
6
Evaluation of Colorectal Cancer Screening in Federally Qualified Health Centers.评估联邦合格健康中心的结直肠癌筛查。
Am J Prev Med. 2018 Feb;54(2):190-196. doi: 10.1016/j.amepre.2017.10.007. Epub 2017 Nov 30.
7
Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona.联邦合格医疗中心可扩大亚利桑那州农村地区丁丙诺啡用于阿片类物质使用障碍治疗的可及性。
Health Serv Insights. 2021 Aug 6;14:11786329211037502. doi: 10.1177/11786329211037502. eCollection 2021.
8
Lessening the Impact of Opioid Misuse at a Federally Qualified Health Center in New York: Outcomes of an Integrated Workforce Training Program.减少纽约联邦合格健康中心阿片类药物滥用的影响：综合劳动力培训计划的结果。
Public Health Rep. 2023 May-Jun;138(1_suppl):42S-47S. doi: 10.1177/00333549231170216.
9
Access to Federally Qualified Health Centers and HIV Outcomes in the U.S. South.美国南部获得合格联邦健康中心服务与 HIV 结局的关系。
Am J Prev Med. 2024 May;66(5):770-779. doi: 10.1016/j.amepre.2023.12.008. Epub 2023 Dec 13.
10
Patient predictors of substance use disorder treatment initiation in primary care.患者预测因素在初级保健中物质使用障碍治疗的启动。
J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28.
本文引用的文献
1
Medicaid participation among practitioners authorized to prescribe buprenorphine.获准开具丁丙诺啡的从业者的医疗补助参与情况。
J Subst Abuse Treat. 2022 Feb;133:108513. doi: 10.1016/j.jsat.2021.108513. Epub 2021 Jun 1.
2
Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study.2017 - 2018年联邦处方政策变化后丁丙诺啡处方配药率及特征：一项横断面研究。
Drug Alcohol Depend. 2020 Aug 1;213:108083. doi: 10.1016/j.drugalcdep.2020.108083. Epub 2020 May 25.
3
Medication-assisted therapies--tackling the opioid-overdose epidemic.药物辅助治疗——应对阿片类药物过量流行问题
N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23.
4
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.丁丙诺啡维持治疗与安慰剂或美沙酮维持治疗用于阿片类物质依赖的比较
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD002207. doi: 10.1002/14651858.CD002207.pub4.
Zotero 插件